Pharma Industry News

A collection of Pharma latest news, analysis and best practices from top business influencers and the world's most trustworthy sources.

globenewswire.com - Zealand Pharma - Zealand Pharma major shareholder announcement: Van Herk Investments B.V.
Zealand Pharma major shareholder announcement: Van Herk Investments B.V.
GlobeNewswire

Company announcement – No. 17 / 2025 Zealand Pharma major shareholder announcement: Van Herk Investments B.V. Copenhagen, Denmark, July 18, 2025 – Zealand Pharma A/S (“Zealand”) (NASDAQ: ZEAL) (CVR-no. 20045078), a…

afr.com - Michael Smith - Jefferies, Mayne Pharma in spotlight in after suitor's court win
Jefferies, Mayne Pharma in spotlight in after suitor's court win
Australian Financial Review

Jefferies Australia will come under intense scrutiny after US medicines giant Cosette successfully sought confidential modelling, which it says could prove Mayne Pharma provided incomplete financial information that ultimately led to its $672…

benzinga.com - Benzinga Insights - Is the Market Bullish or Bearish on Verona Pharma? - Verona Pharma (NASDAQ:VRNA)
Is the Market Bullish or Bearish on Verona Pharma? - Verona Pharma (NASDAQ:VRNA)
Benzinga

Verona Pharma's short percent of float has fallen 14.44% since its last report. The company recently reported that it has 7.21 million shares sold short, which is 8.83% of all regular shares that are available for trading. Based on its trading…

cointelegraph.com - Advertorial - GSR leads $100M into MEI Pharma to launch Litecoin treasury strategy
GSR leads $100M into MEI Pharma to launch Litecoin treasury strategy
Cointelegraph

July 18, 2025 – GSR, crypto's capital markets partner, today announced an investment and strategic partnership with MEI Pharma, Inc. (NASDAQ:MEIP) (“MEI”), in which it will serve as both strategic advisor and digital asset…

business-standard.com - Capital Market - Indices trade lower; pharma shares under pressure
Indices trade lower; pharma shares under pressure
Business Standard

The key equity benchmarks continued to trade with significant cuts in mid-morning trade despite positive global cues. Investors are monitoring India-US trade deal and ongoing corporate earnings. The Nifty hovered below 25,000 level Pharma shares…

benzinga.com - Murtuza J Merchant - First Strategy, Now MEI Pharma: Litecoin Joins Bitcoin As Treasury Asset - MEI Pharma (NASDAQ:MEIP)
First Strategy, Now MEI Pharma: Litecoin Joins Bitcoin As Treasury Asset - MEI Pharma (NASDAQ:MEIP)
Benzinga

MEI Pharma has launched a $100 million Litecoin treasury program, backed by Titan Partners Group and crypto investment firm GSR. The move includes the appointment of Charlie Lee, the creator of Litecoin, to MEI's Board of Directors. The Litecoin…

coinpedia.org - Nidhi Kolhapur - MEI Pharma Unveils $100M Litecoin Treasury, Becomes First Public Firm To Hold LTC As Reserve
MEI Pharma Unveils $100M Litecoin Treasury, Becomes First Public Firm To Hold LTC As Reserve
Coinpedia Fintech News

MEI Pharma is making headlines with the announcement of a bold new Litecoin treasury strategy. The move, confirmed on Friday, positions MEI as the first publicly traded company to adopt Litecoin as a primary treasury reserve asset. In a press…

business-standard.com - SI Reporter - Why AstraZeneca Pharma share price is down over 2% today
Why AstraZeneca Pharma share price is down over 2% today
Business Standard

AstraZeneca Pharma share price: Shares of pharma major AstraZeneca Pharma India dropped 2.5 per cent to ₹9,165 per share during intraday deals on Friday and continued to trade lower. At around 2:20 PM, they were trading at…

business-standard.com - Capital Market - Natco Pharma Ltd spurts 0.35%, gains for five straight sessions
Natco Pharma Ltd spurts 0.35%, gains for five straight sessions
Business Standard

Natco Pharma Ltd is quoting at Rs 1036.4, up 0.35% on the day as on 12:44 IST on the NSE. The stock is down 15.28% in last one year as compared to a 1.65% gain in NIFTY and a 10.63% gain in the Nifty Pharma. Natco Pharma Ltd rose for a fifth…

business-standard.com - Press Trust of India - Torrent Pharma seeks CCI nod for ₹19,500 cr majority stake in JB Chemicals
Torrent Pharma seeks CCI nod for ₹19,500 cr majority stake in JB Chemicals
Business Standard

Ahmedabad-based Torrent Pharmaceuticals has sought fair trade regulator CCI's clearance to acquire a majority stake in in J B Chemicals and Pharmaceuticals in a Rs 19,500-crore deal. After the completion of the deal, Torrent Pharmaceuticals will…

fiercepharma.com - Hard to know what's going to happen': Big Pharmas put brave face on looming tariff threat
Hard to know what's going to happen': Big Pharmas put brave face on looming tariff threat
Fierce Pharma

The opening salvo of second-quarter earnings calls this week came against President Donald Trump's renewed calls for a tariff on pharmaceuticals. The long-threatened tariffs will arrive “ probably at the end of the month,” the…

seekingalpha.com - Edmund Ingham - Iovance: Switching From Sell To Buy Despite Likely Approval For Rival Drug (NASDAQ:IOVA)
Iovance: Switching From Sell To Buy Despite Likely Approval For Rival Drug (NASDAQ:IOVA)
Seeking Alpha

Iovance Biotherapeutics, Inc. stock is down nearly 30% since my 'sell' recommendation in April. Q1 earnings disappointed, with Amtagvi sales underperforming the Street's expectations and guidance revised downward. The impending approval of a rival…

forbes.com - Amy Gu - Rethinking Inventory: Real-Time Data And Edge Tech In Industry 4.0
Rethinking Inventory: Real-Time Data And Edge Tech In Industry 4.0
Forbes

Amy Gu, CEO and Cofounder at Dynamsoft. Industry 4.0 is not just about automation. It's about smart systems that sense, adapt, predict and act in real time. One example is inventory control, which was once a centralized back-office function but has…

wsj.com - Health Care Roundup: Market Talk
Health Care Roundup: Market Talk
Wall Street Journal

The latest Market Talks covering the Health Care sector. Published exclusively on Dow Jones Newswires at 4:20 ET, 12:20 ET and 16:50 ET. 0621 GMT – GSK's Blenrep blood-cancer drug seems unlikely to get U.S. Food and Drug Administration…

globenewswire.com - ALK Abello - EURneffy approved as the first needle-free anaphylaxis treatment of adults and children in the UK
EURneffy approved as the first needle-free anaphylaxis treatment of adults and children in the UK
GlobeNewswire

ALK (ALKB:DC / OMX: ALK B) today announced that the Medicines and Healthcare Products Regulatory Agency (MHRA) has approved EUR neffy 2 mg in the United Kingdom (UK) for anaphylaxis treatment of adults and children (≥30 kg). The market…

Receive a Daily briefing on Pharma Industry News

Get Started